Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
VICL
Ongoing trial completion date December 19, 2019.
Echo20
frrol
Is there an ORPHAN designation on B also?
Echo20
Maxdud
Try not to step down on IPIX too hard. Others might follow you.
Let the FDA meeting go ahead. Let the BTD happen if possible.
Maybe even K.
Echo20
VICL
VICL keeps buying and selling.
Some potentials there.
Up tp $1.23 now?
Echo20
Maxdud
No and if the FDA allows b trials to end well it will be good for IPIX.
BTD will look good also.
P data unlock also.
Would you allow those to occur?
Lots of downs on IPIX.
Echo20
Maxdud
Releasing P data could be a great action now.
The FDA allowing B trial to end successfully could be a good move for IPIX.
Getting the $10 million dollars would be great now.
Echo20
IPIX
If Patrick COX did put a BUY out on IPIX and a new price target of $4.00 that is also a good sign.
Echo20
bradfordbros
I hope you are accurate.
If the FDA allows the B trials to end successfully IPIX will gain.
Echo20
addone33320
If the FDA allows the B trial to end successfully B will become more valuable
Then possibly BTD also.
Echo20
IPIX
If the FDA allows the B trial to end successfully there can be added interest in B. PLus any and all special designations like ORPHAN and FAST TRACK and BTD. Those can be worth a lot to any buying pharmas. 20? TERM SHEET?
UNBLINDED DATA ON P?
Echo20
IPIX
Leo and Dr. B need to get to the very best effort between P and B and K now.
Very critical.
CRO on P or K or B?
Careful placing of the money.
Echo20
georgejji
I hope you are right.
Do we get the BTD? Fast TRACK? ORPHAN Designation?
Echo20
scottsmith
The value of IPIX is in the formulas and special designations already obtained.
Just a few cents down yesterday. Value is in the formulas like P and B.
Echo20
Lets get unblinded and see better.
Monday and next week.
Have a better weekend.
Echo20
kfcyahoo
I know what you mean.
The P data can be very good and as such is needed to be known. Once out and UNBLINDED that could work well for IPIX.
BLINDED that information is not known by Leo, the investors and the pharmas. BLINDED. BLIND Leading the BLIND. PLUS UPSET. SUPER UPSET.
Known, that information can be valuble and worth a lot to all concerned and in time.
Echo20
IPIX
The investors and PHARMAS and IPIX and Leo are all blinded as to the information on PRURISOL at this time.
Once they can all see the true information on P they will know better. Think better. Act better. Make better decisions.
IPIX has many designations like FAST RACK, ORPHAN and BTD. Those can be very valuable to any pharma.
P and B also.
Echo20
KFCyahoo
You point to the potentials of P now as did Scottsmith.
The data gets unblinded and a good chance for good results from that clinical trial. investors will think better unblinded.
Now Leo and Dr.B. and B results instead of wonder.
Eccho20
Scottsmith
There you have a lot of potential for P results?
Well put. Now Leo needs get those potentials to the correct person to in time.
Echo20
warrrenTSI
Well put and sorry the cost is high.
The cost of Prurisol could allow that to be more popular A valid point.
Lower cost medicine can be more popular.
May Prurisol work and for far less money to patients!
Best of success.
Echo20
zandant
P works and once the data is unblinded it will show up in real.
Blind investors do not make good decisions.
B works and that is known and so should get the BTD and in time.
Echo20
georgejji
The P data can show that once unblinded. Investors can see better when not blinded.
The P data potentials can add to the value of IPIX as well as all of the other designations like ORPHAN, FAST TRACK and BTD! Show those each. Add those up.
Echo20
scottsmith
Please state your thoughts on P data value.
Echo20
MAXdud
Poor post. Very poor.
Try for the upper prices.
Echo20
geoprgejji
Add up all of the Fast Track, Orphan and BTD additional benefits on each IPIX medicine.
Those will be worth a lot of money to any buying pharma.
Echo20
November 25, 2015
FDA Grants Fast Track Designation to Cellceutix’s Brilacidin-OM for Oral Mucositis
Brilacidin
BEVERLY, MA–(Marketwired – November 25, 2015) - Cellceutix Corporation (OTC: CTIX) (the “Company”), a clinical stage biopharmaceutical company developing innovative therapies with oncology, dermatology, anti-inflammatory and antibiotic applications, is pleased to announce that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation for Brilacidin-OM, an oral rinse formulation of the Company’s novel defensin-mimetic Brilacidin, for the prevention of oral mucositis. Oral mucositis, a common and often debilitating inflammation and ulceration that occurs in the mouth as a side-effect of certain cancer treatments, afflicts approximately 450,000 patients each year in the United States and can affect the course and outcome of cancer therapy. There are no FDA approved drugs for the prevention of oral mucositis.
Go Faster IPIX
Echo20
Jtorrence
That needs to be put out as well as all of the beneficial values added to IPIX products that can be worth $300 million dollars each. We are blinded at this time.
Echo20
Klinsmann
Looks like VICL could have some potentials.
Echo20
KarinCA
Some additives can be worth ,$300 million dollars for each formula.
Echo20
KarinCA
IPIX has many added benefits on each medicine. Those added up are super valuable to any pharma who buys any formula of IPIX.
Echo20
Jtorrence
IPix needs to find out and the amounts owed the CRO. Those paid and the P data can be unlocked and unblinded and then we will see better.
Echo20
DaubersUp
Hope it does not take until December.
Echo20
Rdunn88
Very positive of you now.
P results could unlock IPIX and after a lot of time and money. Waiting.
Echo20
The Dane
Now being the 12th of October the potentials of the unlocking of the P data can occur as well as the BTD designation combined with all of the other designaions with IPIX can make IPIX look a lot better. There are several of those and that can make IPIX more attractive to any prospective pharma.
Then the B potentials can add to also.
Echo20
MXDUD
P DATA UNLOCK COULD UNLOCK THE POTENTIALS OF IPIX.
THEN MAYBE YOUR INVESTMENT WILL GAIN AND GO UP.
ECHO20
Klinsmann
Just to see if you have any added information. Not insider information.
Thanks.
Echo20
Dane
That was not meant to you only.
To IPIX investors.
Echo20
Maxdud
Leo has stated the approximate costs.
Maybe blinded investors do not think that good.
Lets get unblinded first.
Echo20
The Dane
Within 30 days and from a private family could mean sensitive.
Sensitive could mean careful.
Echo20
bradfordbros
They have enough to pay for P and enough to work out a deal. And enough to pay their scientists to bring on a btd. and maybe a little left over to boot.
If Dr. Mennon has been at all accurate. If the P results are good.
If IPIX did work carefully on P. The results are good. Then we could turn out alright with the unlocking of P data.
Best of success.
Echo20
scottsmith
IPIX HAS BEEN WAITING TO PAY THE CRO FOR A LONG TIME.
TRIAL, TIME AND RESULTS.
P RESULTS COULD BE IMPORTANT.
ECHO20